The dynamic therapeutic effect of a targeted photothermal nanovaccine incorporating toll-like receptor 7 agonist enhanced cancer immunotherapy
Journal of Materials Chemistry B · 2023
DOI: 10.1039/d3tb01345f ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2023. Verfasst von Laxmanan Karthikeyan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bio-Nano Theranostics Research Laboratory, Cancer Research Program (CRP), School of Life Sciences, Bharathiar University, Coimbatore-641 046, TN, Ind…. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Photothermal therapy (PTT) is a noninvasive and effective thermal therapeutic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bio-Nano Theranostics Research Laboratory, Cancer Research Program (CRP), School of Life Sciences, Bharathiar University, Coimbatore-641 046, TN, India. vivekr@buc.edu.in.
- Department of Chemistry, Dr. N.G.P. Arts and Science College, Coimbatore, Tamil Nadu-641048, India.
ORCID-Profile: Raju Vivek
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Karthikeyan, L., Rithisa, B., & Vivek, R. (2023). The dynamic therapeutic effect of a targeted photothermal nanovaccine incorporating toll-like receptor 7 agonist enhanced cancer immunotherapy. Journal of Materials Chemistry B. https://doi.org/10.1039/d3tb01345f
Vancouver
Karthikeyan L, Rithisa B, Vivek R. The dynamic therapeutic effect of a targeted photothermal nanovaccine incorporating toll-like receptor 7 agonist enhanced cancer immunotherapy. Journal of Materials Chemistry B. 2023. doi:10.1039/d3tb01345f
BibTeX
@article{Karthikeyan2023,
author = {Karthikeyan, Laxmanan and Rithisa, Babu and Vivek, Raju},
title = {The dynamic therapeutic effect of a targeted photothermal nanovaccine incorporating toll-like receptor 7 agonist enhanced cancer immunotherapy},
journal = {Journal of Materials Chemistry B},
year = {2023},
doi = {10.1039/d3tb01345f}
}
EUVIMED